Chiara Battistini
7PUBLICATIONS
48CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Apr 28, 2025
Navitoclax, a Bcl-2/xL Inhibitor, and YM155, a Survivin Inhibitor, in Combination with Carboplatin, Effectively Inhibit Ovarian Cancer Tumor Growth.Hilary A Kenny, Carman Ka Man Ip, Lucy Kelliher
|Feb 03, 2025
Early tolerance and late persistence as alternative drug responses in cancer.Simona Punzi, Davide Cittaro, Guido Gatti
|May 28, 2024
Tumor microenvironment-induced FOXM1 regulates ovarian cancer stemness.Chiara Battistini, Hilary A Kenny, Melissa Zambuto
|Mar 28, 2023
Matrix Gla Protein drives stemness and tumor initiation in ovarian cancer.V Nieddu, V Melocchi, C Battistini
|Jan 21, 2023
Patient-Derived In Vitro Models of Ovarian Cancer: Powerful Tools to Explore the Biology of the Disease and Develop Personalized Treatments.Chiara Battistini, Ugo Cavallaro
|Jan 21, 2022
Ovarian Cancer Cells in Ascites Form Aggregates That Display a Hybrid Epithelial-Mesenchymal Phenotype and Allows Survival and Proliferation of Metastasizing Cells.Sonia Capellero, Jessica Erriquez, Chiara Battistini
Pageof 2
Frequent Collaborators
5 joint publications
Ugo Cavallaro
2 joint publications
Valentina Nieddu
2 joint publications
Valentina Melocchi
2 joint publications
Fabrizio Bianchi
2 joint publications
Ernst Lengyel
1 joint publications
G Franciosa
1 joint publications
M Lupia
1 joint publications
G Bertalot
1 joint publications
J V Olsen
1 joint publications
Marco Avolio
